Across TCGA pan-cancer cohorts, RNA5SP328 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNA5SP328 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher RNA5SP328 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP328 expression acts as an unfavorable survival marker.
THCA, STAD, and LUSC are the cancer types where RNA5SP328 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.